CRP and chronic obstructive pulmonary disease: The second tool evaluated was the COPD Predict app that used patient-reported outcomes (PRO), FEV1, and C-reactive protein (CRP), predicting AECOPD with 97.9% sensitivity and 84.0% specificity [65].